Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) is a peer-reviewed, Open Access journal that publishes original research and review articles focusing on cardiovascular and clinical pharmacology, as well as clinical trials of new cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies, and pharmacoepidemiology are also encouraged.
Subject areas include (but are by no means limited to):
Acute coronary syndrome
Arrhythmias
Atherosclerosis
Basic cardiac electrophysiology
Cardiac catheterization
Cardiac remodeling
Coagulation and thrombosis
Diabetic cardiovascular disease
Heart failure (systolic HF, HFrEF, diastolic HF, HFpEF)
Hyperlipidemia
Hypertension
Ischemic heart disease
Vascular biology
Ventricular assist devices
Molecular cardio-biology
Myocardial regeneration
Lipoprotein metabolism
Radial artery access
Percutaneous coronary intervention
Transcatheter aortic and mitral valve replacement.
《Cardiovascular Therapeutics》是一本由WILEY-HINDAWI出版商出版的專業醫學期刊,該刊創刊于2008年,刊期Quarterly,該刊已被國際權威數據庫SCI、SCIE收錄。在中科院最新升級版分區表中,該刊分區信息為大類學科:醫學 4區,小類學科:心臟和心血管系統 4區;藥學 4區;在JCR(Journal Citation Reports)分區等級為Q2。該刊發文范圍涵蓋心臟和心血管系統等領域,旨在及時、準確、全面地報道國內外心臟和心血管系統工作者在該領域取得的最新研究成果、工作進展及學術動態、技術革新等,促進學術交流,鼓勵學術創新。2021年影響因子為3.368,平均審稿速度平均6月。
大類學科 | 分區 | 小類學科 | 分區 | Top期刊 | 綜述期刊 |
醫學 | 4區 | CARDIAC & CARDIOVASCULAR SYSTEMS 心臟和心血管系統 PHARMACOLOGY & PHARMACY 藥學 | 4區 4區 | 否 | 否 |
JCR分區等級 | JCR所屬學科 | 分區 | 影響因子 |
Q2 | CARDIAC & CARDIOVASCULAR SYSTEMS | Q2 | 3.368 |
PHARMACOLOGY & PHARMACY | Q3 |
影響因子 | h-index | Gold OA文章占比 | 研究類文章占比 | OA開放訪問 | 平均審稿速度 |
3.368 | 39 | 100.00% | 77.78% | 開放 | 平均6月 |